Covid-19: FDA approves use of convalescent plasma to treat critically ill patients
- PMID: 32217555
- DOI: 10.1136/bmj.m1256
Covid-19: FDA approves use of convalescent plasma to treat critically ill patients
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical